Leveraging Reverse Translation to Improve Drug Combination Efficacy in the Clinic for Lung Cancer

Time: 10:00 am
day: Day Two


• Strategizing learnings from the clinic and combining late-assets with approved drugs in a combination approach to improve efficacy

• Developing models that recapitulate patient vulnerability using clinical biomarker endpoints

• Implementing in vitro and mouse models to study patient drug resistant mechanism